01 1Alivus Life Sciences
01 1DABIGATRAN ETEXILATE MESYLATE(PROCESS II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-13
Pay. Date : 2022-02-15
DMF Number : 36794
Submission : 2022-02-17
Status : Active
Type : II
20
Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DABIGATRAN ETEXILATE MESYLATE(PROCESS II), with a corresponding US DMF Number 36794.
Remarkably, this DMF maintains an Active status since its submission on February 17, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 13, 2022, and payment made on February 15, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
